Active Solicitation · DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs is seeking vendors capable of providing Hematologic Malignancy Next Generation Sequence testing and Immunohistochemistry testing at the Richard L. Roudebush VAMC. This Sources Sought Notice is for planning purposes only and responses are due by July 14, 2026. Interested vendors should submit their capability statements and relevant information.
SOURCES SOUGHT NOTICE This Sources Sought Notice is to determine the presence of any businesses capable of satisfying a requirement at the Richard L. Roudebush VAMC for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NOTE TO RESPONDERS: This Sources Sought Notice is for planning purposes only and shall not be considered as an invitation for bid, request for quotation, request for proposal, or as an obligation on the part of the Government to acquire any products or services. Your response to this Sources Sought Notice will be treated as information only. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor submission of responses to this announcement or the Government use of such information. This request does not constitute a solicitation for proposals or the authority to enter negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. BACKGROUND The Hematology department at Richard L. Roudebush VA Medical Center s Pathology & Laboratory Medicine Service (PALMS) requires a one-year, firm fixed price contract for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NGS testing is an advanced test methodology at the gene level for detecting various forms of diseases through patient blood specimens. Testing shall provide detailed gene test results of at least 600 targeted genes and produce detailed treatment plans. This contract is needed for Hematology providers to obtain repeat NGS testing that may not be covered under the VA National Precision Oncology Program (NPOP) national contract, for patients with changes in their diagnosis. North American Industry Classification System (NAICS) code: 621511 VENDOR CAPABILITY Interested and qualified vendors are encouraged to respond with: Your company s point of contact s name, street address, e-mail address, telephone number, UEI & sam.gov registration, NAICS code, and Socio-economic status (Small Business, Woman Owned Small Business, Service-Disabled Veteran Owned Small Business, etc.), and GSA/FSS Contract Number (if applicable). A capability statement that adequately describes the contractor s ability to meet the requirement. Contractor shall provide any applicable past performance on contracts of this nature. Please provide no more than three (3) examples. Interested parties are responsible for adequately marking proprietary information contained in their response. The Government does not intend to pay for the information submitted in response to this Sources Sought Notice. All information received in response to this notice that is marked as proprietary will be handled accordingly. GOVERNMENT POINT OF CONTACT No phone calls will be accepted. Responses will only be accepted via email, no later than Tuesday July 14, 2026, at 12pm EST. Primary Point of Contact: Jessica D. Bryant Contract Specialist E-mail: Jessica.Bryant5@va.gov Secondary Point of Contact: Tiera T. Sims Contract Specialist E-mail: Tiera.Sims@va.gov
Q301--NGS MALIGNANCY TESTING is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.